about
Influence of CYP2C9 and COX-2 Genetic Polymorphisms on Clinical Efficacy of Non-Steroidal Anti-Inflammatory Drugs in Treatment of Ankylosing Spondylitis.Whole Genome Expression Profiling and Signal Pathway Screening of MSCs in Ankylosing Spondylitis.Serum fatty acid profiles and potential biomarkers of ankylosing spondylitis determined by gas chromatography-mass spectrometry and multivariate statistical analysis.Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases.Infusion of umbilical cord mesenchymal stem cells alleviates symptoms of ankylosing spondylitis.Secukinumab (AIN457) in the treatment of ankylosing spondylitis.Association study of ankylosing spondylitis and polymorphisms in ERAP1 gene in Zhejiang Han Chinese population.Study on the protective effect of the KIR3DL1 gene in ankylosing spondylitis.Effects of icariin on cytokine-induced ankylosing spondylitis with fibroblastic osteogenesis and its molecular mechanism.Mice expressing human ERAP1 variants associated with ankylosing spondylitis have altered T-cell repertoires and NK cell functions, as well as increased in utero and perinatal mortality.Polymorphisms of human leukocyte antigen B*27 on clinical phenotype of spondyloarthritis in Chinese.Changes and clinical significance of CD8+CD122+ T cells in the peripheral blood of patients with ankylosing spondylitis.Influence of TNF and IL17 Gene Polymorphisms on the Spondyloarthritis Immunopathogenesis, Regardless of HLA-B27, in a Brazilian Population.The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic ReviewERAP1 deficient mice have reduced Type 1 regulatory T cells and develop skeletal and intestinal features of Ankylosing Spondylitis
P2860
Q33584246-784EB078-AECC-43B7-BB2D-53DEAC8D3C86Q34721995-999CDD38-43D4-48FE-A77E-13BF6D97581FQ35253379-56EB44D7-38BE-493D-A4EB-101FD6215842Q35614331-437B416D-4C00-4431-8E86-51782DB958F3Q38646267-1ED9B805-FC11-49EB-83BA-83BE67D06D8AQ38777116-7D28B427-1E2C-4E35-B3D1-A01865EC5036Q40561874-CF15A35B-2A3D-4A46-A5DC-351C21B6BD9EQ40665446-47474A3B-9DDA-4EFD-AAFA-2341A2B45A44Q43127169-0BFF0CA8-BF6C-4F86-89CB-328EEE3A46C3Q47666252-FBA7B455-B780-413A-B69D-1A2A96EE4BD7Q48250672-4DE032CB-A127-40A8-9842-EFF886D070C2Q50129709-D5A820F8-4943-48E1-AB12-ECFC32523C82Q54966906-AD86D5D0-A6A8-469D-BE69-9E7A26C86850Q57538743-9A63EEB3-E43B-4D69-BF4F-B8B94C5EF89AQ58737249-0E5F049A-3AE6-4BEE-96DA-9891FFB3646D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ankylosing spondylitis: from cells to genes
@en
Ankylosing spondylitis: from cells to genes.
@nl
type
label
Ankylosing spondylitis: from cells to genes
@en
Ankylosing spondylitis: from cells to genes.
@nl
prefLabel
Ankylosing spondylitis: from cells to genes
@en
Ankylosing spondylitis: from cells to genes.
@nl
P2093
P2860
P356
P1476
Ankylosing spondylitis: from cells to genes
@en
P2093
Christian González-Reyes
Juan Manuel Agraz-Cibrian
Ma de Jesús Durán-Avelar
Norberto Vibanco-Pérez
P2860
P304
P356
10.1155/2013/501653
P577
2013-07-21T00:00:00Z